Blog

Artificial intelligence.
Human ingenuity.

AlignBio Tournament 2024: Exazyme Achieves Top-Tier Rankings, Highlighting the Power of Its Cutting-Edge Algorithms

Exazyme excels at AlignBio Tournament 2023 and showcases the power of its cutting-edge algorithms. More than 30 teams participated in the first benchmarking event and were asked to show their computationl Protein Prediction and Design capabilities.

DealMonitor: 468 invests in Gauss Robotics – Exazyme secures €2 million – D2C Angels bet on ingarden

Exazyme, Berlin-based AI-Biotech startup, secures €2M Series A funding from AIX Ventures & Atlantic Labs. Discover how we revolutionize Protein Design.

Never give up and always believe in your own mission!

Explore Exazyme’s discourse with Startup Valley, delving into insights, challenges, and pivotal roles. Uncover the transformative impact of our AI technology on enzyme development.

Exazyme secures €2 million in funding for AI-assisted protein development

The Berlin-based start-up Exazyme has won over two renowned venture capitalists, AIX Ventures and Atlantic Labs, and received €2 million in seed capital.

From Science to Startup: Martin Rahmel’s Journey in Green Chemistry Entrepreneurship

Follow Martin Rahmel’s journey to entrepreneurship in green chemistry. Learn about startup challenges, mindset, and the role of the Chemical Invention Factory.

Season 1

Painful Intelligence: Aapo Hyvärinen on the Concept of Suffering, Drawing Parallels between Humans and AI, and Conclusions for AI Ethics.

Optimized Molecules: A Berlin-based startup uses Artificial Intelligence to enhance the effectiveness of enzymes.

Faces of Future: Dr. Ingmar Schuster

Funding for AI-supported protein development: Berlin-based startup Exazyme secures €2 million from AIX Ventures and Atlantic Labs.

Follow us on LinkedIn for the latest updates